A Safety and Tolerability Study of CP-690,550 in Subjects With Hepatic Impairment and Normal Hepatic Function
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate how CP-690,550 is handled by the body in healthy
volunteers who have mild and moderate hepatic impairment compared to healthy volunteers with
normal hepatic function. This study will also evaluate the safety and tolerability of
CP-690,550.